| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $943.71M | $705.14M | $787.65M | $587.37M | $810.46M |
| Cost of Revenue | $15.91M | $11.21M | $9.13M | $14.12M | $10.84M |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $915.62M | $901.53M | $899.63M | – | $638.20M |
| SG&A | $393.87M | $267.47M | $232.62M | $150.29M | $186.35M |
| Operating Income | -$381.68M | -$475.08M | -$353.73M | -$410.19M | -$30.19M |
| Interest Expense | $17.26M | $16.99M | $12.66M | $8.12M | $9.35M |
| Tax Expense | $1.79M | -$6.17M | $32.32M | $11.74M | -$551.00K |
| Net Income | -$381.39M | -$453.90M | -$366.29M | -$269.72M | -$28.60M |
| EPS (basic) | -2.3800 | -3.0400 | -2.5600 | -1.9000 | -0.2000 |
| EPS (diluted) | -2.3800 | -3.0400 | -2.5600 | -1.9000 | -0.2000 |
| Shares (diluted) | $160.01M | $149.51M | $143.19M | $141.85M | $141.02M |